Sartorius Stedim Biotech SA (SDMHF)
254.56
+10.46
(+4.29%)
USD |
OTCM |
Oct 29, 16:00
Sartorius Stedim Biotech Enterprise Value : 27.21B for Oct. 29, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 29, 2026 | 27.21B |
| October 28, 2026 | 26.19B |
| October 27, 2026 | 25.70B |
| October 26, 2026 | 25.70B |
| October 23, 2026 | 25.70B |
| October 22, 2026 | 25.70B |
| October 21, 2026 | 25.24B |
| October 20, 2026 | 25.31B |
| October 19, 2026 | 25.31B |
| October 16, 2026 | 25.99B |
| October 15, 2026 | 25.99B |
| October 14, 2026 | 25.99B |
| October 13, 2026 | 25.99B |
| October 12, 2026 | 25.99B |
| October 09, 2026 | 25.99B |
| October 08, 2026 | 26.18B |
| October 07, 2026 | 26.18B |
| October 06, 2026 | 26.18B |
| October 05, 2026 | 26.18B |
| October 02, 2026 | 26.18B |
| October 01, 2026 | 26.18B |
| September 30, 2026 | 26.18B |
| September 29, 2026 | 26.27B |
| September 28, 2026 | 26.45B |
| September 25, 2026 | 26.10B |
| Date | Value |
|---|---|
| September 24, 2026 | 26.17B |
| September 23, 2026 | 26.06B |
| September 22, 2026 | 25.20B |
| September 21, 2026 | 25.24B |
| September 18, 2026 | 24.30B |
| September 17, 2026 | 24.30B |
| September 16, 2026 | 24.22B |
| September 15, 2026 | 22.96B |
| September 14, 2026 | 22.96B |
| September 11, 2026 | 23.92B |
| September 10, 2026 | 23.92B |
| September 09, 2026 | 24.81B |
| September 08, 2026 | 24.81B |
| September 04, 2026 | 24.81B |
| September 03, 2026 | 24.81B |
| September 02, 2026 | 24.81B |
| September 01, 2026 | 24.81B |
| August 31, 2026 | 24.81B |
| August 28, 2026 | 24.81B |
| August 27, 2026 | 23.65B |
| August 26, 2026 | 23.65B |
| August 25, 2026 | 23.65B |
| August 24, 2026 | 23.65B |
| August 21, 2026 | 23.65B |
| August 20, 2026 | 23.65B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agilent Technologies, Inc. | 53.27B |
| Bio-Rad Laboratories, Inc. | 10.03B |
| Bruker Corp. | 11.10B |
| Azenta, Inc. | 1.532B |
| Danaher Corp. | 188.80B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 110.91M |
| Revenue (Quarterly) | 876.81M |
| Total Expenses (Quarterly) | 766.94M |
| EPS Diluted (Quarterly) | 1.129 |
| Gross Profit Margin (Quarterly) | 44.99% |
| Profit Margin (Quarterly) | 12.65% |
| Earnings Yield | 1.52% |
| Operating Earnings Yield | 2.67% |
| Normalized Earnings Yield | 1.749 |